{
    "Trade/Device Name(s)": [
        "Chemtrue Multi-Panel Drug Screen Cup Tests",
        "Chemtrue Multi-Panel Drug Screen Cup with OPI 2000 Tests",
        "Chemtrue Drug Screen Dip Card Tests",
        "Chemtrue Drug Screen Dip Card with OPI 2000 Tests"
    ],
    "Submitter Information": "Chemtron Biotech, Inc.",
    "510(k) Number": "K153192",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061718",
        "K103295",
        "K060896",
        "K142396",
        "K143599"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "JXN",
        "DKZ",
        "LFG",
        "DIO",
        "LDJ",
        "DNK",
        "LAF",
        "LCM",
        "JXM",
        "DIS",
        "DJC",
        "DJR"
    ],
    "Summary Letter Date": "April 1, 2016",
    "Summary Letter Received Date": "April 4, 2016",
    "Submission Date": "April 12, 2016",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3170",
        "21CFR862.3150",
        "21CFR862.3250",
        "21CFR862.3610",
        "21CFR862.3700",
        "21CFR862.3650",
        "21CFR862.3620",
        "21CFR862.3640",
        "21CFR862.3870",
        "21CFR862.3910"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Benzodiazepines Test System",
        "Barbiturates Test System",
        "Cocaine and metabolites Test System",
        "Methamphetamine Test System",
        "Propoxyphene Test System",
        "Opiate Test System",
        "Methadone Test System",
        "Morphine Test System",
        "Cannabinoids Test System",
        "Tricyclic Antidepressant Drugs Test System",
        "Unclassified, Enzyme immunoassay Phencyclidine"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Barbiturates",
        "Benzodiazepines",
        "Buprenorphine",
        "Cocaine",
        "Marijuana",
        "Methamphetamine",
        "Morphine",
        "Phencyclidine",
        "Ecstasy",
        "Methadone",
        "Oxycodone",
        "Propoxyphene",
        "Tricyclic Antidepressants"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Competitive binding immunoassay",
        "Colloidal gold-based assay"
    ],
    "Methodologies": [
        "Immunochemistry",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Dip Card",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for Chemtrue Multi-Panel Drug Screen Dip Card/Cup Tests for rapid qualitative detection of drugs of abuse in urine using lateral flow immunoassay technology.",
    "Indications for Use Summary": "Rapid lateral flow immunoassays for qualitative detection of Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Marijuana, Methamphetamine, Morphine, Phencyclidine, Ecstasy, Methadone, Oxycodone, Propoxyphene and Tricyclic Antidepressants in human urine for prescription and OTC use.",
    "fda_folder": "Toxicology"
}